Interval-compressed chemotherapy in patients with Ewing's sarcoma: report on feasibility and toxicity from a North African center
{{output}}
Background: Ewing's sarcoma (ES) is the second most common malignant bone tumor in patients under 20 years of age. The "Euro-Ewing 2012" trial established induction therapy with the 2-week-interval VDC/IE (Vincristine-Doxorubi... ...
